Authors/Disclosures
|
Clementine Karageorgiou, MD
(Neurological Institute of Athens)
|
The institution of Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for GENESIS PHARMA. The institution of Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for TEVA-SPECIFAR. |
|
David O. Kamson, MD
(Johns Hopkins University)
|
The institution of Dr. Kamson has received research support from Maryland Cigarette Restitution Fund. The institution of Dr. Kamson has received research support from AACR. The institution of Dr. Kamson has received research support from Metavivor. The institution of Dr. Kamson has received research support from NIH. |
|
|
No disclosure on file |
|
Clementine Karageorgiou, MD
(Neurological Institute of Athens)
|
The institution of Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for GENESIS PHARMA. The institution of Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for TEVA-SPECIFAR. |
|
Carlen A. Yuen, MD
(University of California, Irvine)
|
Dr. Yuen has nothing to disclose. |
|
Clementine Karageorgiou, MD
(Neurological Institute of Athens)
|
The institution of Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for GENESIS PHARMA. The institution of Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for TEVA-SPECIFAR. |
|
Asimina Athanasouli
|
Asimina Athanasouli has nothing to disclose. |
|
Themistokles Kalamatas
(General Anthens Hospital)
|
No disclosure on file |